pharmacokinetics of semaglutide A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability oral in healthy Chinese subjects - Xie - 2024 Single-dose pharmacokinetics of sublingual semaglutide

Tirzepatide Dosing Starting dose: 2.5 mg weekly Maintenance doses: 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly Dose increased every 4 weeks as tolerated Retatrutide Dosing (in Clinical Trials) Studied doses: 1 mg up to 12 mg weekly Common trial doses: 4 mg, 8 mg, or 12 mg weekly Gradual titration over several weeks to minimize side effects Important: Retatrutide dosing is not yet finalized since its still in clinical trials

Doctors in Delray Beach might choose it for its effectiveness and safety

For postpartum women, semaglutide offers several advantages

And Wegovy , the version of semaglutide that is approved for weight loss, might be a better option overall